Development of Fecal Microbiota Transplantation Suitable for Mainstream Medicine.

Link to article at PubMed

Development of Fecal Microbiota Transplantation Suitable for Mainstream Medicine.

Clin Gastroenterol Hepatol. 2014 Nov 20;

Authors: Khoruts A, Sadowsky MJ, Hamilton MJ

Abstract
Fecal microbiota transplantation has emerged as an increasingly common treatment of patients with refractory Clostridium difficile infection. Although it can be relatively simple to perform, a number of challenges need to be overcome before this procedure is widely accepted in mainstream clinical practice. Most of the solutions to these challenges already exist, but some need further optimization and testing. Standardized fecal microbiota is being developed as a therapeutic agent, although it clearly challenges some of the existing paradigms of drug development, delivery, and regulation.

PMID: 25460566 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.